Navigation Links
Prostate Cancer Discovered in 40 Percent of Men Who Test Negative for the Disease
Date:12/15/2008

WESTMONT, Ill., Dec. 15 /PRNewswire/ -- Forty percent of men with prostate cancer may not even know they have it, according to a new research study by the Prostate Cancer Foundation of Chicago. The study revealed the standard office biopsy procedure often isn't enough to properly detect prostate cancer. This new research will be published in an upcoming issue of Urology, a national medical journal.

Researchers used an advanced biopsy technique called stereotactic transperineal prostate biopsy (STPB). This was performed on patients with persistent elevated prostate specific antigen (PSA) levels who previously had at least one negative office biopsy. All patients had received transrectal prostate biopsies (TRPB), administered by a urologist.

"Men who have negative transrectal biopsies and continue to have elevated PSA levels should consider STPB because 40% will harbor malignancy," says Michelle Braccioforte, director of research and education for the Prostate Cancer Foundation of Chicago. "Our level of confidence is greatly enhanced with regards to the presence or absence of cancer, and more specifically, the exact location of the cancer within the prostate."

STPB is performed by taking a median of 40 samples of the prostate through the perineum while the patient is under general anesthesia. Performed as an outpatient procedure, it allows more comprehensive sampling, compared to the transrectal method, which takes fewer samples through the rectum. In addition, by taking more samples during STPB, the exact location of the cancer can be pinpointed.

Between April 2004 and January 2008, 747 patients with high PSA levels were studied. All patients had been tested using TRPB at least once and all results had been negative. All patients received the STPB. Biopsy results identified the presence of cancer in 291 (39%) of the patients.

One in six men in the U.S. will be diagnosed with prostate cancer, the most common form of cancer among men. For those with elevated or rising PSA levels, this is a sign that further testing should be administered to rule out prostate cancer.

The Prostate Cancer Foundation of Chicago, located in Westmont, IL, is a not-for-profit organization that conducts ongoing research intended to improve the diagnosis and treatment of prostate cancer. For more information, visit http://www.chicagoprostatefoundation.org to download or call Michelle at 630.654.2515.


'/>"/>
SOURCE The Prostate Cancer Foundation of Chicago
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. USAs largest ever prostate cancer screening program shows high compliance and consistent results
2. Treadmill Desks More Effective in Decreasing Prostate Cancer Risks Than Vitamin and Antioxidant Supplements
3. Hormone therapy for prostate cancer does not appear to increase cardiac deaths
4. Selenium, Vitamins E and C Wont Prevent Prostate Cancer
5. Study finds selenium, vitamin E do not prevent prostate cancer
6. Single Men Less Likely to Get Prostate Screens
7. Treatment Options Are Many for Prostate Cancer
8. ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
9. ESPNs Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
10. Prostate Cancer Stimulates Nerve Growth
11. Prostate cancer drug reduces testosterone levels in as little as 3 days
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today that ... Supplier Horizon Award . One of ... was recognized for its support of Premier members through ... clinical excellence, and commitment to lower costs. ... this recognition of our outstanding customer service from Premier," ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... , June 23, 2016 The ... it continues to present great opportunities to investors. Stock-Callers.com ... today: Intrexon Corp. (NYSE: XON ), Vertex ... Inc. (NASDAQ: ARNA ), and Regeneron Pharmaceuticals ... these stocks and receive your complimentary trade alerts at: ...
Breaking Medicine Technology: